Repligen Quote - RGEN

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

167.92

Bid

160.01

Ask

268.67

Volume

0.00 Day's Range 0.00

113.50 52 Week Range 211.13

Market Cap

9.408B

Previous Close

167.92

Open

Last Trade

166.11

Last Trade Time

03:23:25

Financial Volume

VWAP

Average Volume (3m)

579,875

Shares Outstanding

56,026,725

Dividend Yield

PE Ratio

264.32

Earnings Per Share (EPS)

0.64

Revenue

662.93M

Net Profit

35.6M

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceuti... Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.repligen.com

Headquarters

Wilmington, Delaware, USA

Founded

Repligen Corp is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker RGEN. The last closing price for Repligen was US$167.92. Over the last year, Repligen shares have traded in a share price range of US$ 113.50 to US$ 211.13.

Repligen currently has 56,026,725 shares outstanding. The market capitalization of Repligen is US$9.41 billion. Repligen has a price to earnings ratio (PE ratio) of 264.32.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	7.72	4.81897627965	160.2	168.42	151.67	745019	162.51723231	CS
4	23.03	15.8948167575	144.89	168.42	140.62	496312	155.83080873	CS
12	34.36	25.7262653489	133.56	168.42	121.52	579875	146.30063245	CS
26	42.42	33.8007968127	125.5	172.65	121.52	686961	147.16585225	CS
52	-10.68	-5.97984322508	178.6	211.13	113.5	646848	153.96607884	CS
156	-12.06	-6.70074452717	179.98	262.26	110.45	592113	165.78697846	CS
260	66.45	65.4873361585	101.47	327.32	78.41	533133	169.52727765	CS

RGEN - Frequently Asked Questions (FAQ)

What is the current Repligen share price?

The current share price of Repligen is US$ 167.92

How many Repligen shares are in issue?

Repligen has 56,026,725 shares in issue

What is the market cap of Repligen?

The market capitalisation of Repligen is USD 9.41B

What is the 1 year trading range for Repligen share price?

Repligen has traded in the range of US$ 113.50 to US$ 211.13 during the past year

What is the PE ratio of Repligen?

The price to earnings ratio of Repligen is 264.32

What is the cash to sales ratio of Repligen?

The cash to sales ratio of Repligen is 14.19

What is the reporting currency for Repligen?

Repligen reports financial results in USD

What is the latest annual turnover for Repligen?

The latest annual turnover of Repligen is USD 662.93M

What is the latest annual profit for Repligen?

The latest annual profit of Repligen is USD 35.6M

What is the registered address of Repligen?

The registered address for Repligen is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Repligen website address?

The website address for Repligen is www.repligen.com

Which industry sector does Repligen operate in?

Repligen operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
IPAImmunoPrecise Antibodies Ltd	US$ 0.7756 (57.32%)	7.93M
CDIOCardio Diagnostics Holdings Inc	US$ 0.8751 (43.93%)	6.89M
NEHCNew Era Helium Inc	US$ 3.875 (41.42%)	1.27M
ADAGAdagene Inc	US$ 2.50 (41.08%)	3
NFXLDirexion Daily NFLX Bull 2X Shares	US$ 45.04 (27.70%)	7.63k
ABLAbacus Life Inc	US$ 3.01 (-59.97%)	31
ARTVArtiva Biotherapeutics Inc	US$ 5.31 (-24.89%)	2
HTLMHomesToLife Ltd	US$ 5.97 (-23.66%)	10
TMCITreace Medical Concepts Inc	US$ 7.23 (-22.01%)	11
ELVNEnliven Therapeutics Inc	US$ 17.21 (-21.77%)	1
IPAImmunoPrecise Antibodies Ltd	US$ 0.7756 (57.32%)	7.93M
CDIOCardio Diagnostics Holdings Inc	US$ 0.8751 (43.93%)	6.89M
ASSTAsset Entities Inc	US$ 1.14 (26.67%)	5.73M
RIMEAlgorhythm Holdings Inc	US$ 0.0398 (15.03%)	4.81M
SHViShares Short Treasury Bond ETF	US$ 110.365 (0.01%)	3.55M